Where did u get the annual revenue from? Also I haven't done my research but it looks like they only get a percentage of the income from the sales, because it is being funded by another company.
Well instead of being a smart#$%$ you could try to answer the question. Oh and btw I guess the company has no idea that they aren't in the biotech industry. Below is found off of their own website, so unless someone hacked into their website and changed the first sentence then I would say they are in the biotech industry. Maybe you should email them and tell them they are wrong.
I have looked online, I am just looking for someone to give me some information I may have not found, and not some smart #$%$ comment.
ABOUT COMBIMATRIX CORPORATION
CombiMatrix Corporation is a diversified biotechnology business that develops proprietary technologies, including products and services in the areas of drug development, genetic analysis, molecular diagnostics, nanotechnology and defense and homeland security markets, as well as in other potential markets where our products and services could be utilized. The technologies we have developed include a platform technology to rapidly produce user-defined, in-situ synthesized, oligonucleotide arrays for use in identifying and determining the roles of genes, gene mutations and proteins. This technology has a wide range of potential applications in the areas of genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences and nanotechnology. Other technologies include proprietary molecular synthesis and screening methods for the discovery of potential new drugs. Combimatrix Molecular Diagnostics, Inc. ("CMDX"), our wholly owned subsidiary located in Irvine, California, has developed capabilities of producing arrays that utilize bacterial artificial chromosomes, which also enable genetic analysis. CMDX functions primarily as a diagnostics reference laboratory.
So I have been doing some research and I understand most small cap biotechs aren't profitable, but does this stock have a pipeline with new products coming to the market? They have some products currently but it seems they are still a long way to profitability. What I out there to even make you think it would be profitable? I am trying to find answers and not bash the stock.
Thanks for your help.
I have been searching everywhere, but did psti give any specific information on the preclinical data for muscle injury other than there was an improvement? I'm not a pumper or basher, and I am long but the insider sales do make me nervous.
Thanks for your time.
I have been in this stock for almost a year now. I originally got in for the stroke data potential. Is there any type of data or public preliminary work that shows that the UC phase 2 will be positive? The only thing I could find was osir data.
Sentiment: Strong Buy